| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.39B | 27.88B | 22.55B | 7.02B | 3.71B | 2.97B |
| Gross Profit | 31.54B | 25.35B | 15.95B | 6.51B | 3.43B | 2.68B |
| EBITDA | 5.13B | 4.08B | 4.44B | 957.92M | -1.49B | -1.84B |
| Net Income | 2.90B | 2.61B | 3.30B | 534.19M | -1.83B | -2.10B |
Balance Sheet | ||||||
| Total Assets | 66.50B | 67.17B | 23.21B | 24.65B | 12.04B | 5.00B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 7.51B | 3.38B | 4.28B | 2.40B | 1.84B |
| Total Debt | 31.15B | 31.83B | 11.83B | 17.24B | 9.88B | 4.73B |
| Total Liabilities | 38.44B | 38.85B | 16.32B | 21.74B | 11.84B | 5.78B |
| Stockholders Equity | 28.06B | 28.33B | 6.88B | 2.91B | 192.60M | -784.43M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.80B | 7.50B | -110.27M | -7.82B | -1.99B |
| Operating Cash Flow | 0.00 | 4.29B | 7.74B | -109.96M | -7.82B | -1.51B |
| Investing Cash Flow | 0.00 | -3.88B | -1.66B | -728.20M | -415.30M | -650.87M |
| Financing Cash Flow | 0.00 | 4.04B | -6.94B | 2.19B | 8.80B | 2.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥979.71B | 25.41 | 11.06% | 2.88% | 11.00% | 88.70% | |
75 Outperform | ¥243.81B | 8.22 | ― | 2.67% | 2.29% | -4.12% | |
64 Neutral | ¥151.58B | 10.72 | 14.78% | 2.95% | 17.74% | 19.41% | |
63 Neutral | ¥160.47B | 20.44 | 8.95% | 3.39% | 28.94% | 109.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥48.24B | -26.35 | ― | 3.75% | -8.66% | -53.57% | |
55 Neutral | ¥43.74B | 13.12 | ― | 1.60% | 116.30% | -0.08% |